Age and physiological status, like menopause, are risk factors for breast cancer. Less clear is what factors influence the diversity of breast cancer. In this study, we investigated the effect of host age on the distribution of tumor subtypes in mouse mammary chimera consisting of wildtype hosts and Trp53 nullizygous epithelium, which undergoes a high rate of neoplastic transformation. Wild-type mammary glands cleared of endogenous epithelium at 3 weeks of age were subsequently implanted during puberty (5 weeks) or at maturation (10 weeks) with syngeneic Trp53 null mammary tissue fragments and monitored for 1 year. Tumors arose sooner from adult hosts (AH) compared to juvenile hosts (JH). However, compared to AH tumors, JH tumors grew several times faster, were more perfused, exhibited a 2-fold higher mitotic index and were more highly positive for insulin-like growth factor receptor across data sets. These data support the notion that age-associated host physiology greatly influences the intrinsic subtype of breast cancer.
Introduction
Breast cancer is a heterogeneous disease, or rather, a collection of neoplastic diseases. As tumor characteristics are highly correlated with prognosis, there has been considerable investment in defining classes and standardizing the characterization of breast tumors based on traditional pathology, marker analysis, imaging features and molecular analysis. Human epidermal growth factor receptor 2 (HER2) amplification distinguishes a specific breast cancer subtype that provides a robust molecular target in therapy (1) . Estrogen receptor (ER) status is important not only because ER-positive tumors are managed with anti-estrogen treatments but also because ER status is with different age groups and with different outcomes. ER-negative tumors are more frequent in young women and have a worse prognosis (2) . Among ERnegative breast cancers there are also several diseases. ER-and progesterone receptor (PR)-negative cancers tend to be poorly differentiated and aggressive. Triple-negative breast cancer that lack both hormone receptors and HER2 amplification are usually invasive ductal carcinomas that have a high rate of relapse (3) .
Molecular profiling discriminates between 5 and 20 tumor types depending on the algorithms and datasets employed (reviewed in (4)). As defined by Perou, transcriptomic analysis of human breast cancer comprises at least six different intrinsic molecular subtypes: luminal-A, luminal-B, HER2, basal-like, claudin-low, and normal-like (5-7). Molecular classification is not synonymous with clinical marker status using ER, PR and HER2. For example, although ERpositive tumors predominate in post-menopausal women and have a relatively low relapse rate, molecular characterization revealed that ER-positive breast cancers can be divided into the socalled luminal A cancers, which are associated with a longer disease-free survival than that of luminal B cancers. The luminal A and B subtypes are known to maintain the expression of ESR1 transcript and protein, along with the canonical mammary luminal fate regulators GATA3 and FOXA1 (8, 9) , but the luminal B subtype has a strong signature of proliferation.
While tumor characteristics are clearly linked with prognosis, it is less clear how these distinct features arise. One source of biological distinction between breast tumors is thought to be the cell of origin at transformation (10) . A "cells of origin" autonomous view of breast cancer is bolstered by several studies in which disruption of the progenitor fate regulator, BRCA1, via promoters specific to the basal mammary gland compartment, produced tumors that resembled human basal-like breast cancers (11) (12) (13) . Alternatively, deregulation of key transcriptional regulator, whether by mutation or epigenetic alteration, may divert cells to a particular state. Author Manuscript Published OnlineFirst on October 3, 2014; DOI: 10.1158/0008-5472. CAN-14-1440 associated with the luminal subtype of breast cancers (14) (15) (16) . External factors are suggested by epidemiological studies of girls exposed to ionizing radiation, who develop triple-negative breast cancer at an early age (17, 18) , and the association of specific tumor types with obesity (19) . Several recent studies have turned attention on the stroma to derive prognostic value by using expression profiling of stromal and extratumoral tissues (20) . Using microdissected stroma from breast cancer, Finak et al. found a stroma-derived prognostic predictor that stratifies disease outcome based on a signature of immune mediators, hypoxia and angiogenesis (21) . Analysis of the expression profiles from invasive breast cancer and ductal carcinoma in situ provides evidence that stromal biology is a key determinant of progression (22) . Consistent with the influence of distinct microenvironment subtypes, an active versus inactive cancer-adjacent microenvironment is associated with aggressiveness and outcome of ER-positive human breast cancers (20) .
The stromal factors that contribute to breast cancer subtype distribution are not mutually exclusive and may be further influenced by more systemic processes. We used a mouse model to show that mice exposed to ionizing radiation and subsequently transplanted with unirradiated donor tissue preferentially develop ER-negative breast cancers (23) . These tumors exhibit a gene expression program characterized by signatures of inflammation and stem cell biology.
Somewhat surprisingly, the murine host radiation profile also segregates sporadic human breast cancers according to intrinsic subtype, i.e. basal from luminal, and within basal cancers, the irradiated murine host profile mediated by TGFβ associated with claudin-low cancers (24) . This bioinformatic analysis suggests that common processes may underlie the etiology of both radiation-preceded and sporadic basal-type cancers. These data led to the hypothesis that host biology profoundly influences the etiology of breast cancer intrinsic subtypes (25) .
As puberty is a period of significant physiological changes that alters the hormonal milieu that in turn directs mammary morphogenesis, in this study we used a mammary chimera model to compare the development of Trp53 null cancer as a function of host age. More tumors arose from Trp53 null outgrowths in adult mice compared to those transplanted during puberty, but the influence of puberty was manifested in development of rapidly growing, strongly ER-positive luminal tumors. We found that the transcriptional profile of the features that differ between tumors arising from juvenile versus adult transplantation segregates human luminal intrinsic breast cancer subtypes. 
Methods
Animals. All animal experiments were performed at Lawrence Berkeley National Laboratory with institutional review and approval. BALB/c mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed four per cage, fed with Lab Diet 5008 chow and water ad libidum.
Trp53 null BALB/c mice were bred in-house under similar conditions. For transplantation experiments, the epithelial rudiments in inguinal glands of 3-week-old mice were surgically removed. At 5 or 10 weeks of age, both cleared mammary glands of host mice were transplanted with a ~1 mm 3 corrected) were exported from Beadstudio and read into R/Bioconductor using the Lumi package. Intensity values were then log2 transformed and quantile normalized. Background subtraction was not performed. The main effect of no background correction for Illumina data is that the fold-change estimation for low expression probes tends to be lower, but low expression yet high fold-change probes are more likely to be false positives. Gene expression data is archived on GEO under accession number GSE56726.
Unsupervised hierarchical clustering was done using Gene Cluster v3.0 software and heatmaps were visualized using Java TreeView v1.1.4r3 software. Expression data was mean centered. analysis was done in a tandem-bootstrapping scheme as previously described (23) . This approach derived a profile of 243 genes modulated by at least 1.5-fold in JH tumors, in 100% (13/13) of the secondary bootstraps. Enriched pathways within the 243 genes were identified with Ingenuity Pathway Analysis.
Statistical Analysis. Statistical analysis was performed using Prism (GraphPad). Time to 2x2mm
3 tumor occurrence per informative fatpad was plotted using the Kaplan-Meier method with significance determined by the log-rank test. Tumor growth curves in a treatment group were fitted to an exponential curve and then averaged into one curve for each treatment group, as previously reported (23) . Differences between treatment groups was determined using the Chi-square test, Mann-Whitney test or two-tailed Student's t-test, which were considered statistically significant at p<0.05. The K-S test was used to determine the difference in distributions of human breast cancers that were classified by the centroids and then stratified by plotting in two-dimensions.
Results

Age at transplantation affects Trp53 null mammary carcinogenesis
The mouse mammary gland develops after birth, starting at 4 weeks of age with the onset of the ovarian hormones of puberty. The inguinal mammary gland can be divested of its endogenous epithelia at three weeks of age (27) . Afterwards, a mammary fragment from a donor mouse can be transplanted into the empty fat pad and it will grow out to form a ductal tree after 6-8 weeks.
Here, we employ the mammary chimera model to test the effect of age by characterizing the occurrence and type of tumors arising from Trp53 null outgrowths initiated in a host undergoing puberty compared to those that arise from transplantation into an adult. Trp53 null mammary fragments from 8-to 10-week-old syngeneic donors were transplanted into 5 week-old (juvenile) or 10 week-old (adult) BALB/c hosts; tumor occurrence was monitored for 13 months after transplantation ( Figure 1A ). Significantly more palpable tumors were obtained in mice that were adults at transplantation ( Figure 1B ).
The extent of morphogenesis and successful transplantation frequency were comparable regardless of age at transplantation and the average size of neoplastic nodules (i.e. those that did not form frank, palpable tumors) evident in carmine-stained outgrowth wholemounts was similar for transplantation at each host age (data not shown). Age at transplantation did not affect the distribution of tumor histopathology(summarized in supplemental table 1), which included adenocarcinomas, spindle cell carcinomas, and squamous carcinomas as previously reported for this Trp53 null model (23) . AH tumors (n=89) had a median latency of 347 days, and 55% of informative fatpads were tumor-bearing by experiment termination. In contrast, the median latency of JH tumors (n=55)
could not be calculated since only 27% of informative fatpads developed palpable tumors.
Transplantation during puberty results in more aggressive tumors
Although fewer tumors arose from transplantation during puberty, once the tumor was detected, JH tumors grew significantly faster compared to adult hosts ( Figure 2A ). The tumor growth rate of tumors arising from transplantation to adults was comparable to that observed in previous experiments (23) . Moreover the difference of tumor growth rate was replicated in cohort of mice transplanted as adults versus juveniles in an independent study (28) . 
Transplantation during puberty results in a luminal breast cancer subtype
The BALB/c Trp53 null mammary transplant model recapitulates the histological (29, 30 ) and molecular diversity of human breast cancer (24, 31) . 80% of the tumors arising from JH were ER+ by the Allred Score (26), compared to 70% ER+ AH tumors ( Figure 3A ), similar to that previously observed from transplantation in adult mice (23, 28) . Furthermore, comparing ER+ tumors between JH and AH tumors, those from JH tumors were much more highly ER+ ( Figure   3C ; JH, mean 11-33%, max >66%; AH, mean 1-10%, max 11-33%). We also examined other canonical luminal markers including progesterone receptor (PR) and Foxa1. 50% of JH tumors (8/16) were positive for PR, compared to less than 40% of AH tumors (4/11). Similarly, the PR immunoreactivity in PR+ tumors from JH tend to be higher (JH, mean 11-30%; AH, mean 2-10%). 80% of JH tumors (8/10) were also positive for Foxa1 while around 70% AH tumors (Cyclin D1) transcripts were also increased, consistent with the increased mitotic index detected in JH tumors (32, 33) . Beyond growth induction, the Areg gene product has been reported to have pro-angiogenic properties, which would be consistent with the increased perfusion observed in JH tumors (34) .
Enhanced IGF1 signaling associates with the luminal subtype of breast cancer
Studies in human and mouse have shown that enhanced IGF signaling is associated with breast cancer phenotype (reviewed in (35)), including poor prognosis (36) , and IGF signaling regulates proliferation in the normal mammary gland (37, 38) . Since JH tumors were highly proliferative (Table S2 ). The proliferation-divested profile showed even stronger segregation of LumB cancer in the Ivshina data set (16% in sub-tree 1, 63% in sub-tree 2; chi-square, p<0.0001) ( Figure 6B ). The same effect was observed on 110 Grade-1 LumA or LumB cancers in (41) in that LumB tumors comprised 10% of sub-tree 1, but 39% of sub-tree 2 (chi-square, p<0.001) ( Figure 6C ). Effective segregation of LumA from LumB cancers without the proliferation-related genes suggests that the JvA 243 profile captures a biological distinction between LumA and LumB that is more than just increased proliferation. Taken together, the bioinformatic analyses suggest that the JvA gene list associates with a distinct luminal breast cancer subtype. 
Models of Luminal Breast Cancer
Discussion
To date, studies using the Trp53 null mammary chimera at different ages, genotypes or physiological states suggest that it is a robust model for studying breast cancer diversity (23, 31, (42) (43) (44) . Our studies using this model suggest that the host environment profoundly influences the type of tumor that eventually develops, long after mammary outgrowth is complete. Here we show that the age at transplantation elicits phenotypically and genomically distinct tumors that have features strongly reminiscent of the human luminal intrinsic subtypes.
Although transplantation of adult hosts generated more tumors compared to those transplanted during puberty, tumors arising from juvenile host grew faster, had more mitoses and were better An intriguing question is how the physiology and microenvironment during puberty promotes the development of highly ER+ mammary cancers. The mammary gland in mice and humans develops into maturity after birth. The onset of puberty initiates the estrus cycle that releases cyclical surges of estrogen and progesterone, two of the main hormones that induce ductal morphogenesis. Concomitantly, growth hormone and IGF stimulate longitudinal growth of the entire organism, while also being essential regulators of mammary gland development (37, 38) .
Phosphorylated IGFR staining was strikingly elevated in the highly ER positive JH tumors compared to AH tumors. Involvement of IGF signaling is consistent with the highly ER-positive luminal phenotype. It has been shown that in mice, serum IGF-1 level was significantly higher during the late puberty (5-8 weeks of age) compared to the level during the early puberty (3-5 weeks of age) (45) . It is possible that this growth factor surge promotes the carcinogenesis of JH tumor while for AH tumor, such growth-stimulation is lacking. This potential mechanism will be investigated in the further studies where different hormones are evaluated at different ages.
Notably proliferation mediated by IGF-1 is important in cancer overall, is strongly associated with poor prognosis in breast tumors (36) and increases susceptibility in familial breast cancer (46) . (50, 51) . Indeed breast cancer molecular subtypes defined by transcriptomic profiling can also be characterized by methylome profiling (52) , suggesting that the two may go hand-in-hand. Identical hypermethylated genes occur in histologically normal ducts that are adjacent to pre-invasive and invasive lesions, suggesting a common loco-regional etiology mediated by methylation (9, 53, 54) .
We speculate that the distinct tumor subtypes that arise as a function of host biology in the mammary chimera model could be rooted in factors that influence cell intrinsic processes of either initiation or early progression during specific physiological states, which in this case is puberty. The relative short age window of 5 weeks between transplantation resulting in JH and AH tumors suggest that events occurring in roughly the first month of transplant outgrowth impacts the specific tumor type. The transplanted tissue fragments contain about 2,000 epithelial cells that contain 1-4 stem cells based on functional repopulation assays (28) . Trp53 null tissue gives rise to morphologically normal ductal outgrowths by 3 months posttransplantation; over the course of the next 6-9 months morphologically aberrant lesions become evident. This effect of transplantation at different ages is consistent with our studies in irradiated hosts in which tumor type was affected even though only the host was irradiated months before tumor development. A strong radiation signature in the mammary gland expression profiles is present at 1 week after exposure, is much less robust at 4 weeks, and is no longer discernable 12 weeks after irradiation, yet is evident in tumors arising months later (23, 28 
In multi-stage carcinogenesis models, cancer is initiated by genomically aberrant cells whose proliferation results in acquisition of additional mutations to establish the malignant phenotype.
Concomitant subversion of tissue suppressive function, evasion of the immune system and recruitment of a permissive stroma involves a dynamic interplay between malignant and nonmalignant cells that is equally important (25) . Our data from the Trp53 mammary chimera model shows that tumor latency and type is highly influenced by differences in host biology at the time of transplantation due to exogenous conditions (e.g. ionizing radiation exposure, diet) or endogenous factors (e.g. host genotype, age). The idea that tumor type is determined by biology outside the epithelial cell genome is provocative in that it suggests that tumor type is not the sum of random genomic alterations and that, once understood, such host biology might be a target for chemoprevention. Extrinsic carcinogenesis processes can be viewed in terms of environmental imprinting or ecological selection, although it is unclear which is more likely without more detailed studies or modeling. The mammary chimera model provides the means to somewhat uncouple cellular (i.e. initiation) and systemic responses to physiological or environmental (e.g. life style) factors during carcinogenesis.
Conclusions
Age is clearly a primary factor associated with the risk of detecting clinically evident cancer, but it has been less clear how age intersects with the carcinogenic process. Here, mammary Trp53 null carcinogenesis advanced more rapidly from transplantation to adult hosts compared to pubertal hosts, but tumors arising from transplantation during puberty had more distinct hallmarks (e.g. faster growth rate, more mitoses, and greater perfusion) than those tumors arising from transplantation to an adult mouse. Preliminary data from middle-aged mice (i.e. 
